MOESM2 of Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

  • Matteo Pallocca (Creator)
  • Frauke Goeman (Creator)
  • Francesca De Nicola (Contributor)
  • Elisa Melucci (Creator)
  • Francesca Sperati (Creator)
  • Irene Terrenato (Creator)
  • Laura Pizzuti (Creator)
  • Beatrice Casini (Creator)
  • Enzo Gallo (Creator)
  • Carla Azzurra Amoreo (Creator)
  • Patrizia Vici (Creator)
  • Luigi Di Lauro (Contributor)
  • Simonetta Buglioni (Creator)
  • Maria Grazia Diodoro (Creator)
  • Edoardo Pescarmona (Creator)
  • Marco Mazzotta (Creator)
  • Maddalena Barba (Creator)
  • Maurizio Fanciulli (Creator)
  • Ruggero De Maria Marchiano (Contributor)
  • Gennaro Ciliberto (Creator)
  • Marcello Maugeri-Saccà (Contributor)

Dataset

Description

Additional file 2. Panel A) Oncoprint illustrating the individual distribution of YAP expression (positive and negative) and TP53 mutations; panel B) Mutation Mapper illustrating the detected mutations represented on the linear protein. Missense variants (green) have been considered for building the YAP+/TP53mut(mv) model.
Dati resi disponibili2018
Editorefigshare

Cita questo